CD8A and cancer: In previous studies, CD8+ T cells are the predominant T cell subset in the tumor microenvironment, and correlated with improved survival outcomes in various cancers, including colorectal cancer (Mansuri et al., 2021), esophageal cancer (Hao et al., 2020), and gastric cancer (Lee et al., 2018).